Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Dionne M Hines"'
Autor:
Nipun Atreja, Kasper Johannesen, Rupesh Subash, Carina Bektur, Melissa Hagan, Dionne M Hines, Iulia Dunnett, Ewa Stawowczyk
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 14, Iss 1 (2024)
Aim: Warfarin and direct-acting oral anticoagulants (DOACs) are widely prescribed to patients with nonvalvular atrial fibrillation (NVAF) to reduce risk of stroke and systemic embolism (SE). This study aimed to assess the cost–effectiveness of ap
Externí odkaz:
https://doaj.org/article/ea9158af1ae84892bd039863e418f338
Autor:
Larry R Jackson, Amiee Kang, Virginia Noxon, Nipun Atreja, Dionne M Hines, Melissa Hagan, Jenny Jiang, Brett D Atwater
Publikováno v:
PLoS ONE, Vol 19, Iss 12, p e0314345 (2024)
IntroductionUse of oral anticoagulants (OACs) for stroke reduction in atrial fibrillation (AF) varies by race and geography within the United States. We seek to better understand the relationship between OAC underutilization, race, and US geography.M
Externí odkaz:
https://doaj.org/article/67637bab8c5b4759ac9da185c3a2217c
Autor:
Alexander Cohen, Virginia Noxon, Amol Dhamane, Robert Bruette, Shrushti Shah, Dionne M. Hines, Tamuno Alfred, Xuemei Luo
Publikováno v:
Thrombosis Research. 226:117-126
Autor:
Alexander T. Cohen, Janvi Sah, Amol D. Dhamane, Dionne M. Hines, Theodore Lee, Lisa Rosenblatt, Birol Emir, Allison Keshishian, Huseyin Yuce, Xuemei Luo
Publikováno v:
Advances in Therapy. 40:1705-1735
Autor:
Steven Deitelzweig, Emi Terasawa, Amiee Kang, Nipun Atreja, Dionne M. Hines, Ahmed Noman, Xuemei Luo
Publikováno v:
Current medical research and opinion. 38(11)
In recent years, US payers have increased usage of formulary exclusions as a means to help manage costs. Earlier this year, one of the largest pharmacy benefit managers in the country added Eliquis (apixaban), the most widely used anticoagulant, to i
Autor:
Alexander T Cohen, Virginia Noxon, Amol D Dhamane, Shrushti Shah, Dionne M Hines, Tamuno Alfred, Jose Chaves, Xuemei Luo
Publikováno v:
Blood. 140:10853-10854
Autor:
Alpesh Amin, Allison Keshishian, Dionne M. Hines, Oluwaseyi Dina, Hannah Le, Lisa Rosenblatt, Xianchen Liu, Qisu Zhang, Lien Vo
To provide an updated comparison of the risk and cost of stroke/systemic embolism (SE) and major bleeding between direct oral anticoagulants (DOAC: apixaban, rivaroxaban, dabigatran) and warfarin among non-valvular atrial fibrillation (NVAF) patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367a44a5a1c7d329153ea97056c3c9c7
Publikováno v:
Patient Preference and Adherence. 13:1927-1939
Objective To assess adherence and persistence with first-line single-tablet regimen (STR) and multi-tablet regimen (MTR) antiretroviral therapy (ART) in newly treated HIV-1 patients. Methods Retrospective analysis of longitudinal pharmacy claims amon
Publikováno v:
HeadacheREFERENCES. 61(4)
OBJECTIVE To describe patient characteristics, adherence, and treatment patterns, among adult migraine patients in the United States prescribed erenumab. BACKGROUND Migraine is a highly prevalent and debilitating disease characterized by recurrent at
Publikováno v:
PharmacoEconomics Open
Objective There are limited real-world data comparing cumulative incremental healthcare costs in people living with HIV (PLWH) and those without HIV. This study evaluated all-cause cumulative and incremental costs in PLWH in the US using a matched-co